Related Experiment Video
Updated: Mar 23, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.4K
Satisfaction and attrition in paediatric weight management
J A Skelton1,2,3, S Martin4, M B Irby1,2
1Department of Pediatrics, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Clinical Obesity
|March 24, 2016
Summary
Paediatric obesity treatment attrition is high, but most children and parents report positive experiences. Logistical challenges, not dissatisfaction, are key reasons for dropout in weight management programs.
Area of Science:
- Pediatrics
- Public Health
- Behavioral Science
Background:
- Paediatric obesity is a significant public health concern.
- High attrition rates plague family-based weight management programs.
- Understanding child and parent perspectives on dropout is crucial.
Purpose of the Study:
- To explore child and parent experiences in a family-based paediatric weight management program.
- To identify key contributors to treatment attrition from the perspectives of children and parents.
Main Methods:
- Semi-structured interviews were conducted with 57 parents and 30 children (completers and dropouts).
- Interviews explored experiences within a family-based weight management program.
- Data were analyzed using a multistage inductive coding approach.
Main Results:
- Five themes emerged: positive program experience, logistical challenges, improved health, differing child/parent perceptions, and importance of structure/expectations.
- Primary dropout reasons included time commitment, distance, missed school/work, lack of adolescent-specific programs, clinic hours, and stress.
- Few participants expressed dissatisfaction; children enjoyed social support and family time.
Conclusions:
- Paediatric weight management programs are generally viewed positively by children and parents.
- Attrition is primarily linked to logistical barriers rather than program dissatisfaction.
- Addressing logistical challenges is vital for reducing dropout rates and improving treatment adherence.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
369
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
369
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
678
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
678
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
443
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
443
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
322
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
322
01:52Regression Toward the Mean
7.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
7.3K
01:21Drug Dosing: Obese Patients
335
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
335